Investment Thesis
UHS demonstrates solid revenue growth of 9.7% YoY and generates healthy operating cash flow of $401.6M, indicating operational resilience in the hospital sector. However, net income growth stalled at 0% YoY despite revenue gains, signaling margin compression from rising operating costs, which combined with poor capital returns (ROE 4.7%, ROA 2.2%) suggests limited earnings growth potential. The company maintains adequate financial stability with manageable debt and strong interest coverage, but insufficient profitability expansion to warrant a buy recommendation.
Strengths
- Strong revenue growth of 9.7% YoY demonstrates market demand and pricing power in healthcare services
- Solid free cash flow generation of $184.5M provides flexibility for debt service and capital allocation
- Strong interest coverage ratio of 13.5x and moderate leverage (Debt/Equity 0.63x) indicate financial stability and low default risk
- Operating margin of 11.2% is healthy for hospital operations segment
Risks
- Net income completely flat (0% growth) despite 9.7% revenue growth indicates significant margin compression from rising labor and operational costs
- Extremely low returns on capital (ROE 4.7%, ROA 2.2%) signal poor efficiency in deploying equity and assets
- Tight liquidity with current ratio of only 1.08x and low cash balance of $119M relative to $15.7B asset base
- Significant debt burden of $4.7B; while manageable, limits financial flexibility in downturns or for strategic investments
Key Metrics to Watch
- Operating margin trends - critical to determine if cost pressures are structural or temporary
- Free cash flow sustainability - monitor if CapEx requirements increase or operating cash generation weakens
- Debt-to-Assets ratio and cash balance changes - assess financial flexibility for operational needs
Financial Metrics
Revenue
4.5B
Net Income
348.7M
EPS (Diluted)
$5.65
Free Cash Flow
184.5M
Total Assets
15.7B
Cash
119.0M
Profitability Ratios
Gross Margin
N/A
Operating Margin
11.2%
Net Margin
7.8%
ROE
4.7%
ROA
2.2%
FCF Margin
4.1%
Balance Sheet & Liquidity
Current Ratio
1.08x
Quick Ratio
1.08x
Debt/Equity
0.63x
Debt/Assets
0.0%
Interest Coverage
13.54x
Long-term Debt
4.7B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-08T06:54:55.217783 |
Data as of: 2026-03-31 |
Powered by Claude AI